{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20201217",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "65616",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021385s006lbl.pdf",
              "date": "20201217",
              "type": "Label"
            },
            {
              "id": "65652",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021385Orig1s006ltr.pdf",
              "date": "20201221",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20031210",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "42132",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-385_Ertaczo.html",
              "date": "20040308",
              "type": "Review"
            },
            {
              "id": "27645",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21385ltr.pdf",
              "date": "20031216",
              "type": "Letter"
            },
            {
              "id": "36802",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21385_Ertaczo_lbl.pdf",
              "date": "20031210",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20140122",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "5233",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021385Orig1s005ltr.pdf",
              "date": "20140123",
              "type": "Letter"
            },
            {
              "id": "36803",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021385s005lbl.pdf",
              "date": "20140123",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20051122",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "5232",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021385s003ltr.pdf",
              "date": "20051130",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA021385",
      "sponsor_name": "LACER PHARMA",
      "openfda": {
        "application_number": [
          "NDA021385"
        ],
        "brand_name": [
          "ERTACZO"
        ],
        "generic_name": [
          "SERTACONAZOLE NITRATE"
        ],
        "manufacturer_name": [
          "Lacer Pharma, LLC",
          "Coral Way Pharma, LLC"
        ],
        "product_ndc": [
          "73159-004",
          "85437-004"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "TOPICAL"
        ],
        "substance_name": [
          "SERTACONAZOLE NITRATE"
        ],
        "rxcui": [
          "250511",
          "580294"
        ],
        "spl_id": [
          "28e14b24-611e-9c6f-e063-6294a90ac043",
          "4ee1de22-cab4-606f-e063-6394a90afd63"
        ],
        "spl_set_id": [
          "27d51f01-3282-34ea-e063-6394a90a91ed",
          "c6fa8dc4-2620-474e-a9b4-6657d9cbfa96"
        ],
        "package_ndc": [
          "73159-004-60",
          "85437-004-60"
        ],
        "unii": [
          "1DV05410M5"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "ERTACZO",
          "active_ingredients": [
            {
              "name": "SERTACONAZOLE NITRATE",
              "strength": "2%"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "CREAM",
          "route": "TOPICAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}